Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Jaca A, Durão S, Harbron J
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde · 16 citations
How it was studied
- Design
- Systematic review (classified by our AI screen)
- Studied in
- People
- Main outcome
- Clinical events such as disease or death
Who paid for it
- Funding
- Independent funding
- Government
- South African Medical Research Council
- Government
- Medical Research Council
Based on 2 listed funder(s).
Publication
- Published
- 2020-11-27 · S Afr Med J · vol. 110 · issue 12 · p. 1158
- Publisher
- Health and Medical Publishing Group
- Cited
- 109 citations · more than 98% of similar papers · 6.6× the field average
- Impact
- Top 10% most cited in its field
- References
- 6 works
- Access
- Open access (journal) · CC-BY-NC
- Research areas
- Fatty Acid Research and Health · Antioxidant Activity and Oxidative Stress · Vitamin K Research Studies
- Keywords
- Primary (astronomy), Secondary prevention, Disease, Medicine, Primary prevention, Internal medicine, Physics
- MeSH
- humans, cardiovascular diseases, fatty acids, omega-3, primary prevention, dietary supplements, south africa, randomized controlled trials as topic, secondary prevention, heart disease risk factors
3 authors
From ZA
- Anelisa JacaSouth African Medical Research Council
- Solange DurãoSouth African Medical Research Council
- Janetta HarbronUniversity of Cape Town
Abstract
Background
Cardiovascular diseases (CVDs) are defined as conditions involving decreased blood flow to the heart that can lead to heart attacks, stroke or other disorders. CVDs are a common cause of death in low- and middle-income countries. In South Africa (SA) in particular, CVD is the leading cause of death after HIV/AIDS, responsible for 1 in 6 deaths. CVD risk factors include unhealthy diets, hypertension, obesity, high cholesterol levels and diabetes. Omega-3 fatty acids may have a protective role in the risk of developing heart disease.
Objectives
To evaluate the consequences of an increased intake of fish and plant-based omega-3 fatty acids on the risk of CVD mortality and events.
Methods
The inclusion criteria for this review were randomised controlled trials (RCTs) lasting at least 12 months, which investigated men and women aged ≥18 years. These participants had to be at any risk of CVD while receiving dietary supplements and an advised diet to promote the intake of omega-3. This diet included oily fish, fish oils and seeds rich in omega-3. Comparisons with the interventions included the participants' usual diet, no advice, no supplements, placebo or lower-dose omega-3. The review evaluated the effectiveness of these interventions on primary (e.g. CVD deaths and events), secondary (e.g. major adverse cerebrovascular or CVD events, body weight and other adiposity measures, and lipids) and tertiary (e.g. blood pressure and side-effects) outcomes.
Results
Evidence from this review indicates that increasing the intake of long-chain omega-3 fatty acids (LCn3) or alpha-linolenic acid (ALA) probably has little or no effect on all-cause CVD or coronary heart disease mortality. Evidence was of moderate certainty, except for all-cause mortality, where there was a high certainty.
Conclusions
According to moderate- to high-certainty evidence, short-chain fatty acids and LCn3 have little or no effect on mortality or cardiovascular health. However, omega-3 ALA slightly reduces the risk of CVD events and arrhythmias.
Abstract via Europe PMC. Copyright remains with the authors or publisher.
Community trust
Loading…
How much do you trust this study's findings?
Comments
Sign in to rate, comment on or flag this study.Sign inSomething wrong here?
Flag this study if its information, labels or funding look wrong. An editor reviews every flag.
Sign in to rate, comment on or flag this study.Sign inEducational information about published research. Not medical advice, and not a recommendation to start or stop anything.